Home » Topics » Regulatory

Regulatory
RSS

Vectibix approved for metastatic colorectal cancer

Sep. 28, 2006

Lamictal approved for new epilepsy indication

Sep. 26, 2006

Idenix receives first approval for novel CHB treatment

Sep. 21, 2006

Lyrica indications broadened in E.U. to include central neuropathic pain

Sep. 19, 2006

Glivec approved in E.U. for additional cancer indications

Sep. 19, 2006

FDA approves first antifungal agent for prevention of IFIs caused by Aspergillus

Sep. 19, 2006

German approval for Foster in asthma

Aug. 31, 2006

Keppra receives FDA approval for juvenile myoclonic epilepsy

Aug. 24, 2006

CE Mark for Repel-CV to reduce adhesions following cardiac surgery

Aug. 24, 2006

Mexico first to approve Januvia

Aug. 9, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.